From genome to therapy: industry perspective.
Herrling
P L
PL
Novartis Pharma AG, Research, Basel, Switzerland.
D004345:Drug Industry; D030342:Genetic Diseases, Inborn / Q000235:genetics; D015894:Genome, Human; D023281:Genomics; D016045:Human Genome Project; D006801:Humans